| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2014 | International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: The EORTC QLQ-CML24 | Efficace F.; Baccarani M.; Breccia M.; Saussele S.; Abel G.; Caocci G.; Guilhot F.; Cocks K.; Naeem A.; Sprangers M.; Oerlemans S.; WEI-CHU CHIE ; Castagnetti F.; Bombaci F.; Sharf G.; Cardoni A.; Noens L.; Pallua S.; Salvucci M.; Nicolatou-Galitis O.; Rosti G.; Mandelli F. | Quality of Life Research | 61 | 48 | |
| 2015 | Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III | Singer S.; Ara?jo C.; Arraras J.I.; Baumann I.; Boehm A.; Brokstad Herlofson B.; Castro Silva J.; WEI-CHU CHIE ; Fisher S.; Guntinas-Lichius O.; Hammerlid E.; Irarr?zaval M.E.; Jensen Hjermstad M.; Jensen K.; Kiyota N.; Licitra L.; Nicolatou-Galitis O.; Pinto M.; Santos M.; Schmalz C.; Sherman A.C.; Tomaszewska I.M.; Verdonck De Leeuw I.; Yarom N.; Zotti P.; Hofmeister D. | Head and Neck | 57 | 50 | |
| 2013 | Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: A methodological review | Singer S.; Arraras J.I.; WEI-CHU CHIE ; Fisher S.E.; Galalae R.; Hammerlid E.; Nicolatou-Galitis O.; Schmalz C.; Verdonck-De Leeuw I.; Gamper E.; Keszte J.; Hofmeister D. | Quality of Life Research | 54 | 50 | |
| 2013 | Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy - Update of the EORTC QLQ-H&N35, Phase i | Singer S.; Arraras J.I.; Baumann I.; Boehm A.; WEI-CHU CHIE ; Galalae R.; Langendijk J.A.; Guntinas-Lichius O.; Hammerlid E.; Pinto M.; Nicolatou-Galitis O.; Schmalz C.; Sen M.; Sherman A.C.; Spiegel K.; Verdonck-De Leeuw I.; Yarom N.; Zotti P.; Hofmeister D. | Head and Neck | 24 | 25 | |
| 2012 | Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals? | Efficace F.; Breccia M.; Saussele S.; Kossak-Roth U.; Cardoni A.; Caocci G.; WEI-CHU CHIE ; Naeem A.; Nicolatou-Galitis O.; Cocks K.; Vignetti M.; Baccarani M.; Mandelli F.; Sprangers M. | Annals of Hematology | 40 | 35 |
